Arpa Garay

Insider Reports History

Location
Kenilworth, NJ
Signature
/s/ James Dillon, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Arpa Garay:

Company Role Class Num Shares Value Price $ Report Date Ownership
Moderna, Inc. Chief Commercial Officer Restricted Stock Units 11,405 $1,140,614 $100.01 05 Dec 2023 Direct
Moderna, Inc. Chief Commercial Officer Common Stock 3,690 $383,391 $103.90 06 Dec 2023 Direct
Merck & Co., Inc. SVP Human Health Global Mktg. Common Stock 2,109 $251,878 $119.43 04 May 2022 Direct
Merck & Co., Inc. SVP Human Health Global Mktg. Restricted Stock Unit 1,819 $234,287 $128.80 04 May 2022 Direct
Merck & Co., Inc. SVP Human Health Global Mktg. Stock Option (Right to Buy) 21,359 03 May 2022 Direct

Insider Reports Filed by Arpa Garay

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MRNA Moderna, Inc. 05 Dec 2023 3 -$44,182 4 Chief Commercial Officer 07 Dec 2023, 16:21
MRNA Moderna, Inc. 05 Sep 2023 3 -$62,219 4 Chief Commercial Officer 07 Sep 2023, 16:46
MRNA Moderna, Inc. 05 Jun 2023 3 -$287,972 4 Chief Commercial Officer 07 Jun 2023, 16:05
MRNA Moderna, Inc. 28 Feb 2023 2 $0 4 Chief Commercial Officer 02 Mar 2023, 16:27
MRNA Moderna, Inc. 28 Jun 2022 0 $0 3 Chief Commercial Officer 29 Jun 2022, 16:04
MRK Merck & Co., Inc. 03 May 2022 4 +$56,441 4 SVP Human Health Global Mktg. 05 May 2022, 17:24
MRK Merck & Co., Inc. 03 May 2022 3 +$48,383 4 SVP Human Health Global Mktg. 04 May 2022, 16:44
MRK Merck & Co., Inc. 01 May 2022 3 +$54,899 4 SVP Human Health Global Mktg. 03 May 2022, 16:11
MRK Merck & Co., Inc. 28 Feb 2022 0 $0 3 SVP Human Health Global Mktg. 10 Mar 2022, 18:15